RxDoctor Payments Data

Sheila Khianey, MD

Cardiovascular Disease · Falls Church, VANPI 1588994255

Payments from drug & device makers

$792in general payments, 2019–2025

Across 14 payments — averaging $56.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$167
  • Amgen$163
  • Novartis$163
  • Edwards Lifesciences$150
  • Vital Connect, Inc$59
  • E.r. Squibb & Sons, L.L.C.$44
  • plus $45 from 2 others

What the payments were for

  • Food & beverage$792100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott2$167
Amgen2$163
Novartis3$163
Edwards Lifesciences1$150
Vital Connect, Inc1$59
E.r. Squibb & Sons, L.L.C.2$44
Bardy Diagnostics, Inc.2$32
Bracco Diagnostics Inc.1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$792 in reported general payments places this provider in the 35th percentile of 548 cardiovascular disease providers in Virginia.

See all cardiovascular disease providers in Virginia

Medicare billing

Part B allowed, 2024
$114,671
Medicare patients
1,546
Services billed
2,292

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban106$141,668
Repatha SureclickEvolocumab38$38,883
XareltoRivaroxaban12$19,371
Metoprolol Succinate82$1,442
Valsartan21$1,435
Nebivolol Hcl14$916
Bumetanide19$915
Rosuvastatin Calcium64$762
Atorvastatin Calcium72$754
Losartan Potassium64$618
Ezetimibe19$561
Amlodipine Besylate92$495
ClopidogrelClopidogrel Bisulfate21$452
Spironolactone43$418
Olmesartan Medoxomil17$418

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Falls Church

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →